Dynamic Causal Modeling of Neuromodulation of Action Speed Via Targeted TMS-EEG

Recruiting N/A Interventional Study
Temporal Perturbation Virtual Lesion EEG fNIRS TMS Stroke Lesions Action Slowing Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
80 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Stroke is a major cause of long-term disability, with cognitive and motor deficits-especially action slowing and executive dysfunction-being strong predictors of poor recovery outcomes. Recent advances in network neuroscience suggest that action speed is governed by interactions between specific prefrontal and premotor regions. However, the precise neural mechanisms underlying action slowing in st…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The control group consists of individuals who are : * neurologically healthy, * meaning they do not have any medical conditions that could interfere with cognitive performance or its measurement. * not have any contraindications for undergoing MRI scans or TMS, such as epileps…
Contacts

GODEFROY Olivier, Pr

33+322668240

Godefroy.Olivier@chu-amiens.fr

CONTACT